Because EBV infection is closely associated with the occurrence of NPC, EBV-related biomarkers, such as EBV viral capsid antigen-specific IgA (VCA-IgA), have been widely used in NPC screening. Here, CD79A is linked to nasopharyngeal carcinoma.